Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Jiangsu Hengrui Medicine Co Ltd
600276Current price
44.97 CNY
-0.26 CNY (-0.57%)
Last closed
45.43 CNY
Company
www.hrs.com.cn
ISIN
CNE0000014W7
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
Shanghai Stock Exchange
Capitalization
284 394 233 788 CNY
Yield for 12 month
+6.56 %
1Y
3Y
5Y
10Y
15Y
600276
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, develops, manufactures, and commercializes drugs worldwide. The company is developing Camrelizumab, Pyrotinib, Fuzuloparib, Adebrelimab, Rezvilutamide, Famitinib, Dalpiciclib, SHR-1701, SHR-1501, SHR-A1811, SHR1459, Mecapegfilgrastim, Apatinib, Linperlisib, and SHR2554 for oncology indications; SHR4640, Retagliptin, SHR20004, SHR-1209, SHR3824, INS068, SHR7280, and SHR2285 for cardiovascular and metabolism indications. It is also developing SHR0302, Hetrombopag, Vunakizumab, and SHR-1703 for autoimmune indications; SHR0410, Imrecoxib, Remimazolam, and SHR8554 for pain; Oteseconazole and HRS9950 for anti-infection; and SHR8028, SHR8058, SHR-1707, and SHR-1222 for other indications. The company was founded in 1970 and is based in Lianyungang, China. Address: No. 38, Huanghe Road, Lianyungang, China, 222000
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
404.66 CNYP/E ratio
51.6279Dividend Yield
–Current Year
+22 913 782 079 CNY
Last Year
+21 362 905 982 CNY
Current Quarter
+7 634 518 668 CNY
Last Quarter
+6 022 238 452 CNY
Current Year
+19 374 013 388 CNY
Last Year
+17 861 905 227 CNY
Current Quarter
+6 700 231 740 CNY
Last Quarter
+5 075 505 364 CNY
Key Figures 600276
1 year
3 years
5 years
10 years
EBITDA
6 032 360 006 CNY
Operating Margin TTM
PE Ratio
51.6279
Return On Assets TTM
7.36 %
PEG Ratio
–
Return On Equity TTM
13.11 %
Wall Street Target Price
404.66 CNY
Revenue TTM
25 356 155 493 CNY
Book Value
6.91 CNY
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
34 %
Dividend Yield
–
Gross Profit TTM
22 241 104 623 CNY
Earnings per share
0.86 CNY
Diluted Eps TTM
0.86 CNY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
96.4 %
Profit Margin
21.49 %
Dividend Analytics 600276
Dividend growth over 5 years
113 %Continuous growth
–Payout Ratio 5 years average
23 %Dividend History 600276
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
12.07.2024
Forward Annual Dividend Yield
–
Last Split Factor
1.2:1
Payout Ratio
–
Last Split Date
10.06.2021
Dividend Date
–
Stock Valuation 600276
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
51.6279
Forward PE
59.5238
Enterprise Value Revenue
10.2976
Price Sales TTM
11.216
Enterprise Value EBITDA
38.8937
Price Book MRQ
6.6451
Financials 600276
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 600276
For 52 weeks
35.66 CNY
49.94 CNY
50 Day MA
42.1 CNY
Shares Short Prior Month
–
200 Day MA
43.31 CNY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart